콘텐츠로 건너뛰기
Merck

M4141

Methanesulfonic acid solution

4 M (with 0.2% (w/v) tryptamine)

동의어(들):

Sulfomethane

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

Linear Formula:
CH3SO3H
CAS 번호:
Molecular Weight:
96.11
UNSPSC Code:
12352209
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-898-6
Beilstein/REAXYS Number:
1446024
MDL number:
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의


form

liquid

Quality Level

concentration

4 M (with 0.2% (w/v) tryptamine)

storage temp.

2-8°C

SMILES string

CS(O)(=O)=O

InChI

1S/CH4O3S/c1-5(2,3)4/h1H3,(H,2,3,4)

InChI key

AFVFQIVMOAPDHO-UHFFFAOYSA-N

Application

For complete protein and peptide hydrolysis with tryptophan recovery. After hydrolysis the samples are diluted prior to amino acid analysis.

Packaging

Ampules sealed under argon.

Disclaimer

air sensitive, store under inert conditions


Still not finding the right product?

Explore all of our products under


pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

저장 등급

8A - Combustible corrosive hazardous materials

wgk

WGK 2

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter



가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문



Gulfam Ahmad et al.
Frontiers in pharmacology, 11, 556020-556020 (2020-10-13)
Chronic inflammatory bowel disease (IBD) is a condition with multifactorial pathophysiology. To date, there is no permanent cure and the disease is primarily managed by immunosuppressive drugs; long-term use promotes serious side effects including increased risk malignancies. The current study
Luke F Gamon et al.
Redox biology, 36, 101586-101586 (2020-06-07)
The precise characterization and quantification of oxidative protein damage is a significant challenge due to the low abundance, large variety, and heterogeneity of modifications. Mass spectrometry (MS)-based techniques at the peptide level (proteomics) provide a detailed but limited picture due
Chris Twelves et al.
Breast cancer research and treatment, 148(3), 553-561 (2014-11-09)
Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women